- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: GI neoplasms (phase 1)
Total 182031 results
-
ProThera, Inc.UnknownOsteoarthritisUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedBecker Muscular Dystrophy | Facioscapulohumeral Muscular Dystrophy | Limb-Girdle Muscular DystrophyUnited States
-
University Hospital, GhentCompletedAdvanced Colorectal CancerBelgium
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedMalignant Tumors | Subcutaneous Tumors | Lymph Node TumorsUnited States
-
University GhentDistracCompletedPressure Ulcer Lesions (Grade 2 or More)Belgium
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedRenal Cell CarcinomaUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedProstatic NeoplasmsUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedSquamous Cell CarcinomaUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
AmgenCompletedAnemia | Non-Small Cell Lung Cancer
-
AmgenCompletedNeoplasm Metastasis | Non-Small Cell Lung Cancer | Lung Cancer
-
Cell GenesysCompletedAcute Myelogenous LeukemiaUnited States
-
Maxygen Holdings Ltd.Parexel; Maxygen ApS; Maxygen, Inc.UnknownBreast Cancer | Chemotherapy-Induced NeutropeniaPoland, Romania, Russian Federation, Ukraine
-
Innovative MedicalTerminated
-
MediQuest TherapeuticsCompletedRaynaud's DiseaseUnited States
-
AmgenCompletedBreast Cancer | Anemia
-
Cell GenesysCompleted
-
Cell GenesysCompletedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalTerminatedBreast CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedColorectal AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; United... and other collaboratorsCompletedBreast Cancer | Menopause | Postmenopausal Bone LossUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedNeoplasm Metastasis | Colorectal CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompleted
-
Callisto PharmaceuticalsCompletedNeuroendocrine CarcinomaUnited States
-
Callisto PharmaceuticalsCompletedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedNon-Small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedBreast CancerUnited States
-
Jagiellonian UniversityCompletedGastric Cancer | Pancreatic CancerPoland
-
National Institute of Arthritis and Musculoskeletal...Completed
-
AstraZenecaCompletedHead and Neck CancerHong Kong, Singapore
-
AstraZenecaCompleted
-
AstraZenecaCompletedPediatric HypertensionUnited States, Hungary, Slovakia, Belgium
-
AstraZenecaCompletedNon Small Cell Lung CarcinomaAustralia
-
Unither PharmaceuticalsTerminated
-
Unither PharmaceuticalsTerminatedOvarian NeoplasmsCanada, United States
-
AstraZenecaCompletedMetastatic Breast CancerNorway
-
NovartisCompletedOsteoarthritis of the KneeUnited States
-
AstraZenecaCompletedGefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck CancerHead and Neck NeoplasmsFinland
-
NSABP Foundation IncAstraZenecaCompletedBreast NeoplasmsUnited States
-
Unither PharmaceuticalsTerminatedOvarian NeoplasmsUnited States
-
Unither PharmaceuticalsTerminated
-
NovartisCompletedAtopic DermatitisJapan
-
Astex Pharmaceuticals, Inc.Eisai Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted